Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Otto Boerman

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Diabetes|November 21, 2014
(111)In-exendin uptake in the pancreas correlates with the β-cell mass and not with the α-cell massMaarten Brom, Lieke Joosten, Cathelijne Frielink, et al.
PET Clinics|July 18, 2014
Preclinical studies of SPECT and PET tracers for NETMaarten Brom, Otto Boerman, Martin Gotthardt, et al.
Immunotherapy|May 4, 2013
Molecular imaging and carbonic anhydrase IX-targeted radioimmunotherapy in clear cell renal cell carcinomaStijn Muselaers, Peter Mulders, Egbert Oosterwijk, et al.
Bioconjugate Chemistry|August 3, 2017
<sup>89</sup>Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art <sup>89</sup>Zr RadiochemistrySandra Heskamp, René Raavé, Otto Boerman, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 7, 2013
In vivo and in vitro studies on renal uptake of radiolabeled affibody molecules for imaging of HER2 expression in tumorsMohamed Altai, Zohreh Varasteh, Karl Andersson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2006
Software package for integrated data processing for internal dose assessment in nuclear medicine (SPRIND)Eric Visser, Ernst Postema, Otto Boerman, et al.
Update on Cancer Therapeutics|March 4, 2008
Cancer Imaging and Therapy with Bispecific Antibody PretargetingDavid M Goldenberg, Jean-Francois Chatal, Jacques Barbet, et al.
Molecular Pharmaceutics|December 12, 2017
Enhanced Specific Activity by Multichelation of Exendin-3 Leads To Improved Image Quality and In Vivo Beta Cell ImagingLieke Joosten, Maarten Brom, Hanneke Peeters, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 30, 2004
Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studiesAdrienne Brouwers, Peter Mulders, Egbert Oosterwijk, et al.
Journal of Biomedical Materials Research. Part A|March 24, 2018
The kinetics and mechanism of bone morphogenetic protein 2 release from calcium phosphate-based implant-coatingsYuelian Liu, Corinne Schouten, Otto Boerman, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Diabetes|November 21, 2014
(111)In-exendin uptake in the pancreas correlates with the β-cell mass and not with the α-cell massMaarten Brom, Lieke Joosten, Cathelijne Frielink, et al.
PET Clinics|July 18, 2014
Preclinical studies of SPECT and PET tracers for NETMaarten Brom, Otto Boerman, Martin Gotthardt, et al.
Immunotherapy|May 4, 2013
Molecular imaging and carbonic anhydrase IX-targeted radioimmunotherapy in clear cell renal cell carcinomaStijn Muselaers, Peter Mulders, Egbert Oosterwijk, et al.
Bioconjugate Chemistry|August 3, 2017
<sup>89</sup>Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art <sup>89</sup>Zr RadiochemistrySandra Heskamp, René Raavé, Otto Boerman, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 7, 2013
In vivo and in vitro studies on renal uptake of radiolabeled affibody molecules for imaging of HER2 expression in tumorsMohamed Altai, Zohreh Varasteh, Karl Andersson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2006
Software package for integrated data processing for internal dose assessment in nuclear medicine (SPRIND)Eric Visser, Ernst Postema, Otto Boerman, et al.
Update on Cancer Therapeutics|March 4, 2008
Cancer Imaging and Therapy with Bispecific Antibody PretargetingDavid M Goldenberg, Jean-Francois Chatal, Jacques Barbet, et al.
Molecular Pharmaceutics|December 12, 2017
Enhanced Specific Activity by Multichelation of Exendin-3 Leads To Improved Image Quality and In Vivo Beta Cell ImagingLieke Joosten, Maarten Brom, Hanneke Peeters, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 30, 2004
Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studiesAdrienne Brouwers, Peter Mulders, Egbert Oosterwijk, et al.
Journal of Biomedical Materials Research. Part A|March 24, 2018
The kinetics and mechanism of bone morphogenetic protein 2 release from calcium phosphate-based implant-coatingsYuelian Liu, Corinne Schouten, Otto Boerman, et al.
Pageof 3